Renal SABR: Implementation of A New Standard of Care
This paper, using a question and answer format, comprehensively explores and presents the data for SABR treatment of patient’s with RCC. The data and clinical care aspects of patient selection, radiotherapy treatment planning and delivery and post-treatment follow-up care are presented.
Category
  • Genitourinary
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $49.00
Providing Equitable Care to Pregnant Patients
Each year in the U.S., thousands of pregnant people will be diagnosed with cancer and face the need for radiotherapy.
Category
  • General RO
  • Patient Safety
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $49.00
Disparities in Gynecologic Cancer Care and Outcomes in the Age of Molecular Profiling and Targeted Therapies: Etiologies and Solutions
In contradistinction to many other malignancies, gynecologic cancers continue to rise in incidence and/or mortality. By 2030, endometrial cancer will be one of the top three female cancers, exceeding colon cancer rates.
Category
  • Gynecologic
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $49.00
Palliative Radiation Therapy for Spine Metastases
This presentation focuses on the management of spine metastases with palliative radiation, emphasizing a multidisciplinary and patient-centered approach incorporating up-to-date clinical practice guidelines and evidence.
Category
  • Central Nervous System
  • Hypofractionation
  • Palliative Care
Format
  • Sessions onDemand
Credits
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 Certificate of Attendance
Cost $149.00
Navigating the Complexities of Brain Metastases and Leptomeningeal Disease Management
The management of patients with brain metastases and leptomeningeal disease (LMD) presents complex clinical challenges requiring nuanced, evidence-based decision-making.
Category
  • Central Nervous System
  • Palliative Care
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
New Tools for Formidable Foes: Strategies for Management of Unresected Soft Tissue Sarcomas
Some patients with soft tissue sarcomas may be inoperable due to medical comorbidity or might decline radical or amputative surgeries due to undesirable functional outcomes.
Category
  • Sarcoma
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
To Radiate or Not to Radiate? Updates to Management of Retroperitoneal Sarcoma
Retroperitoneal sarcomas (RPS), a rare subset of soft tissue sarcomas, account for 10-15% of these cases and are distinguished by their substantial size, infiltrative nature, and proximity to vital anatomical structures.
Category
  • Sarcoma
Format
  • Sessions onDemand
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $149.00
Radiopharmaceutical Therapies: 177Lu-Dotatate and 177Lu-PSMA-617
Radiopharmaceutical therapies have been a breakthrough cancer treatment for tumors resistant to cytotoxic chemotherapy and many new radiopharmaceutical agents are in active development.
Category
  • Radiopharmaceutical Therapy
Format
  • onDemand
  • Webinars
Credits
  • 2.00 AMA PRA Category 1 Credit™
  • 2.00 Certificate of Attendance
Cost $149.00
Radiation as an Immune Catalyst: Techniques, Biology and Biomaterials for Enhancing Tumor Control
Increasing evidence has demonstrated the importance of immunomodulation on tumor control. Radiotherapy, specifically, can produce a multitude of local and systemic immunomodulatory effects, including reprogramming the tumor microenvironment and exposing tumor antigens via in situ vaccination.
Category
  • Immunotherapy
  • Radiobiology
Format
  • Sessions onDemand
Credits
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 Certificate of Attendance
Cost $149.00
Reirradiation with Stereotactic Body Radiation Therapy for Spinal Metastases: Planning Procedure from a High-Volume Multi-Disciplinary Spine Oncology Program (SOaR2)
This journal activity provides practitioners with the knowledge needed to identify indications and technical details of reirradiation of metastatic disease of the spine.This activity is available from May 6, 2026, through 11:59 p.m. Eastern time on May 5, 2028.
Category
  • Central Nervous System
Format
  • Journal Activities
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Certificate of Attendance
Cost $49.00

Pages